DALPIAZ, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 10.958
EU - Europa 2.965
AS - Asia 1.753
SA - Sud America 33
AF - Africa 6
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.726
Nazione #
US - Stati Uniti d'America 10.949
CN - Cina 1.109
UA - Ucraina 930
TR - Turchia 518
IT - Italia 452
DE - Germania 443
GB - Regno Unito 350
SE - Svezia 258
FI - Finlandia 201
PL - Polonia 176
FR - Francia 68
HK - Hong Kong 27
IN - India 27
BR - Brasile 19
BE - Belgio 16
IR - Iran 16
NL - Olanda 15
AT - Austria 14
PK - Pakistan 13
RU - Federazione Russa 12
VN - Vietnam 11
CO - Colombia 9
CA - Canada 8
IQ - Iraq 7
IE - Irlanda 6
JP - Giappone 6
CZ - Repubblica Ceca 5
TH - Thailandia 5
AU - Australia 4
CH - Svizzera 4
KR - Corea 4
RO - Romania 4
EG - Egitto 3
EU - Europa 3
GR - Grecia 3
ID - Indonesia 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
DK - Danimarca 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SG - Singapore 2
SY - Repubblica araba siriana 2
AR - Argentina 1
BG - Bulgaria 1
MN - Mongolia 1
MX - Messico 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 15.726
Città #
Woodbridge 1.460
Fairfield 1.336
Jacksonville 1.010
Houston 998
Chandler 869
Ashburn 626
Ann Arbor 622
Wilmington 556
Seattle 526
Cambridge 480
Izmir 334
Nanjing 294
Princeton 226
Beijing 194
Ferrara 177
Warsaw 176
Boardman 156
San Diego 116
Addison 103
Nanchang 96
Milan 84
New York 83
Shenyang 78
Hebei 73
Shanghai 58
Tianjin 51
Changsha 49
Falls Church 49
Bremen 48
Redwood City 46
San Mateo 46
Dearborn 43
Jiaxing 35
Kunming 32
Norwalk 31
Mountain View 28
Jinan 26
Hong Kong 24
Zhengzhou 22
Helsinki 19
Philadelphia 19
Auburn Hills 18
London 18
Washington 18
Tappahannock 17
Ningbo 16
Verona 15
Düsseldorf 14
Brussels 13
Indiana 13
Lanzhou 13
Orange 13
Los Angeles 12
Bologna 11
Guangzhou 11
Vienna 11
Hangzhou 10
Islamabad 10
Leawood 10
Augusta 9
Rome 9
Dong Ket 8
Guarda Veneta 8
Redmond 8
Taizhou 8
Dallas 7
Medellín 7
Changchun 6
Des Moines 6
Hefei 6
Monmouth Junction 6
Rovere Veronese 6
Amsterdam 5
Ardabil 5
Gurgaon 5
Islington 5
Paris 5
Wuhan 5
Argenta 4
Dublin 4
Haikou 4
Itajaí 4
Masi Torello 4
Modena 4
Taiyuan 4
Bolzano 3
Chicago 3
Codevigo 3
Frankfurt Am Main 3
Hanover 3
Ho Chi Minh City 3
Hounslow 3
Kilburn 3
Moscow 3
Oberengstringen 3
Palermo 3
Pietro 3
San Francisco 3
Sassari 3
Torino 3
Totale 11.739
Nome #
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 240
Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? 196
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 151
Physicochemical stability of cabazitaxel and docetaxel solutions 146
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 143
Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently? 141
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes 139
Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 138
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 133
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles 126
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 121
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 121
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 119
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 119
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity. 118
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 118
Conjugation of aspirin with vitamin C: uptake and stability studies 116
Solid microparticles based on chitosan or methyl-beta-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate 115
From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine 115
Binding thermodynamics at A1 and A2A adenosine receptors 113
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 112
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 110
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 110
Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: effect of steroids, flavonoids and NSAIDs. 109
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 109
Conformational Aspects of Human Formyl-peptide Receptor Agonists 107
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres. 106
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 106
null 106
Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study 105
Progress in drug delivery to the central nervous system by the prodrug approach 104
A concerted binding study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines to mitochondrial benzodiazepine receptors 103
null 103
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 103
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 102
Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight 102
Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor 102
null 101
Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? 101
Exploring the Use of Spray Congealing to Produce Solid Dispersions with Enhanced Indomethacin Bioavailability 101
Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A 1 receptors of LUF5831, a novel nonadenosine-like agonist 100
Peptide derivatives as agonists or antagonists of formylpeptide receptors: analysis of their effects on neutrophils 99
Thermodynamics of full agonist, partial agonist and antagonist binding to wild type and mutant adenosine A1 receptors. 99
Poly(lactic acid) microspheres for the sustained release of antiischemic agents 98
Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents 98
Temperature dependence of the affinity enhancement of selective adenosine A1 receptor agonism: a thermodynamic analysis. 97
Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review 97
Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells 97
Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration 97
Conformational aspects of human formylpeptide receptor antagonists 96
Dopamine-sensitive adenylyl cyclases in neuronal development: physiopathological and pharmacological implications. 95
Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System? 95
Binding thermodynamics of 5-HT(1A) receptor ligands 95
Binding thermodynamics of adenosine A2a receptor ligands 95
Pharmacological and Biochemical Characterization of Purified A2A Adenosine Receptors in Human Platelet Membranes by [3H]-CGS 21680 Binding 94
Determination of the adenosine A1 agonist N6-cyclopentyladenosine in rat blood by solid-phase extraction and HPLC 94
Nuclear Retinoic Acid Receptor Beta as a Tool in Chemoprevention Trials 94
Biochemical and pharmacological characterization of periodate-oxidized adenosine analogues at adenosine A1 receptors. 94
Solid lipid microparticles for the stability enhancement of a dopamine prodrug 93
null 93
Characterization of A2A Adenosine Receptors in Human Lymphocyte Membranes by [3H]-SCH 58261 Binding 93
null 92
null 91
Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H] SCH 58261 binding 91
Thermodynamics of 5-HT3 receptor binding discriminates agonistic from antagonistic behaviour 91
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy (R)) in allergic rhinitis treatment 91
Pharmacological, biochemical and thermodynamic characterization of purified adenosine A2A receptors in human platelet membranes by [3H] CGS 21680 binding 89
Temperature dependence and GABA modulation of b-carboline binding to rat cerebellum benzodiazepine receptors. 88
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 88
null 88
Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in-vivo preclinical pharmacokinetic study 88
From crystal to solution and across the membranes: the case of carbamazepine co-crystals 86
Binding thermodynamics of serotonin to rat brain 5HT1A, 5HT2A and 5HT3 receptors 86
Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation. 85
null 83
Odorants could elicit repair processes in melanized neuronal and skin cells 83
null 83
Drug release from pharmaceutical co-crystals: Are therapeutic and safety properties of active pharmaceutical substances retained? 83
Full and partial agonists and thermodynamic binding parameters of adenosine A1 receptor ligands 82
null 81
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 81
An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity. 80
Incorporation of the polar antiischemic drug N6-cyclopentyladenosine in solid lipid microparticles 79
null 79
Nasal administration and brain targeting of an antiischemic agent 78
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 77
1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one and 5H-pyrazolo[4,3-d] 1,2,3-triazin-4(3H)-one derivatives. Synthesis and in vitro biological activity at adenosine A1 and A2a receptors 77
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 77
null 77
null 76
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 75
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 75
Adenosine A1 receptor: Analysis of the potential therapeutic effects obtained by its activation in the central nervous system 75
The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability 74
Adenosine analogs prodrugs: design, synthesis and chemico-physical characterization of N6-cyclopentyladenosine (CPA) derivatives 72
METODO PER MODULARE L'ASSORBIMENTO FAGOCITARIO DI UN PRINCIPIO ATTIVO O UN SUO PRECURSORE DA PARTE DI MACROFAGI 72
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 71
Neuroactive molecules and their pro-drugs obtained by conjugation with vitamin c: studies of delivery into the brain. 71
Binding therodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 71
Can Thermodynamic Measurements of Receptor Binding Yield Information on Drug Affinity and Efficacy? 71
Totale 10.000
Categoria #
all - tutte 57.427
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.292
Totale 58.719


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.282 0 0 0 0 0 0 0 0 0 0 415 867
2019/20203.470 637 122 125 494 207 391 270 374 244 399 129 78
2020/20212.762 221 314 186 253 94 272 80 297 106 445 364 130
2021/20221.971 50 228 148 120 87 85 77 102 76 163 180 655
2022/20232.003 228 99 53 261 383 312 60 158 250 15 118 66
2023/2024661 120 135 60 25 95 116 35 39 15 21 0 0
Totale 15.985